1070KRW
47.18 BKRW
730.99 BKRW
23.35 M
About DONGKOOK PHARM
Sector
CEO
Joon-Ho Song
Headquarters
Seoul
Website
Employees (FY)
1.13 K
Founded
1968
ISIN
KR7086450004
FIGI
BBG000R6HNL4
DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products include raw materials and finished products of pharmaceuticals, health care products, and medical devices. The company was founded on October 15, 1968 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 086450 is 16220.00 KRW — it has increased by 3.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DONGKOOK PHARM stocks are traded under the ticker 086450.
DONGKOOK PHARM is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DONGKOOK PHARM has a max estimate of 21000.00 KRW and a min estimate of 21000.00 KRW.
DONGKOOK PHARM revenue for the last quarter amounts to 176.40 B KRW despite the estimated figure of 178.45 B KRW. In the next quarter revenue is expected to reach 184.43 B KRW.
Yes, you can track DONGKOOK PHARM financials in yearly and quarterly reports right on TradingView.
Like other stocks, 086450 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DONGKOOK PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 1.13 K employees. See our rating of the largest employees — is DONGKOOK PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DONGKOOK PHARM EBITDA is 87.96 B KRW, and current EBITDA margin is 12.03%. See more stats in DONGKOOK PHARM financial statements.